🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

An international real-world study of primary vitreoretinal lymphoma from the Australasian lymphoma alliance and collaborators buff.ly/CESED9G

Genomic variant profiling in blast-phase paediatric chronic myeloid leukaemia: Predisposing and driving alterations buff.ly/GWzxQb3

The role of blinatumomab in adult acute B lymphoblastic leukaemia buff.ly/Y5bU3Ti

Long-term efficacy and safety of mitapivat in non-transfusion-dependent α- or β-thalassaemia: An open-label phase 2 study buff.ly/NKl0ku8

First comprehensive analysis of disease causing and rare UBA1 variants in UK populations buff.ly/i4hH5Ow

Robust CAR T-cell expansion and superior outcomes in DLBCL patients in complete response at infusion buff.ly/6qniqZy

📣📚 #MeetTheEditor Episode 8: We're excited to introduce you our #AssociateEditor Anjali Advani! Stay tuned! #BrJHaem #Haematology @wileyOnc_Hem BSH - Haematology

Screening for monoclonal gammopathy of undetermined significance is contraindicated buff.ly/13LCjeJ

Combination of fixed low-dose nivolumab and bendamustine in children with high-risk relapsed/refractory classical Hodgkin lymphoma buff.ly/xgwDdx2

Thrombosis risk in MPN patients peaks within 2 years of diagnosis and is later driven by age. This nationwide study highlights the need for early management and age-specific care to optimise outcomes. buff.ly/SdEag9q

Hypoxia in pregnancy and unscheduled Caesarean deliveries are linked with worse immediate postpartum outcomes in sickle cell disease. buff.ly/XGWaNwZ Kevin Kuo A. Kinga Malinowski, MD

NGS-based chimerism testing shows improved sensitivity in post-HCT monitoring compared to STR. Real-world data from a single-center study buff.ly/V1Shjlj

A recent study shows uneven adoption of electronic blood transfusion systems in NHS England, with barriers such as funding and integration. Economic evaluations are crucial to support implementation. buff.ly/aogCWfh

A phase II trial by FIL_ETS investigating copanlisib+BR in R/R DLBCL showed limited efficacy. More effective strategies are needed for this challenging population. Clinical research never stops! buff.ly/bXqlq7H mattia novo

Hot off the press!! 😁 Large-cell transformation of #MycosisFungoides Published in British Journal of Haematology Open access➡️doi.org/10.1111/bjh.20… Congrats & 🙏to Dr Martin Higgins & Dr Pippa Johnstone, 2 super⭐️ former #radonc cutaneous lymphoma fellows at Peter Mac Cancer Centre & joint first authors👏

Largest UK study on AHSCT in MS reports on safety and sustained efficacy of the procedure and highlights uneven geographical access across the country. #AHSCT #MS #autoimmunity #research #therapy buff.ly/izjtjpE

📣📚 #MeetTheEditor Episode 9: We're excited to introduce you our #AssociateEditor Toby Eyre! Stay tuned! #BrJHaem #Haematology @wileyOnc_Hem BSH - Haematology

Anti-thymocyte globulin in immune-mediated cytopenias: A monocentric experience and literature review buff.ly/HiCotLe

Magrolimab, an anti-CD47 antibody, combined with obinutuzumab and venetoclax, is safe and induces durable responses in relapsed/refractory indolent B-cell lymphomas. Rahul Lakhotia Mark Roschewski Christopher Melani buff.ly/xXzEhOI

Simplified Molecular International Prognostic Index as an eligibility criterion for clinical trials: Analysis of the Turkish Lymphoma Study Group's large B-cell lymphoma cohort buff.ly/uF9jtm7